Current therapeutic strategies for invasive and metastatic bladder cancer.
about
The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidenceMelphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma.Targeting PPM1D by lentivirus-mediated RNA interference inhibits the tumorigenicity of bladder cancer cells.Protein interactome of muscle invasive bladder cancer.A comparison of NBI and WLI cystoscopy in detecting non-muscle-invasive bladder cancer: A prospective, randomized and multi-center study.Rottlerin-induced autophagy leads to apoptosis in bladder cancer cells.Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion.BcCluster: A Bladder Cancer Database at the Molecular Level.Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma.Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway.
P2860
Q30845020-A9BF8D09-EC7C-440E-99BF-B6ADD85ACB5BQ34511534-BB507DD5-B80A-491A-ACF4-2430E73425E5Q34574266-6FC09619-0041-412F-BA8C-46040E4B6E10Q34876528-5FAE35FD-17C2-4A93-8AC5-ACD3CEE2D9FDQ35686887-453079EC-F737-432B-89A2-53529AB3144AQ37581641-D42B6914-1EC4-46D1-A4E1-FFCA89A302A3Q37588340-BCBF3AA7-56D6-426C-9D33-00F82C2BFF04Q39634042-BFCD0129-5CC9-4EDE-9B31-50956859974EQ43244789-B38F1256-A402-408C-BA6C-EC8205705E58Q47097592-512E1841-B647-45F5-A2C4-AC92F57C7788
P2860
Current therapeutic strategies for invasive and metastatic bladder cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Current therapeutic strategies for invasive and metastatic bladder cancer.
@ast
Current therapeutic strategies for invasive and metastatic bladder cancer.
@en
type
label
Current therapeutic strategies for invasive and metastatic bladder cancer.
@ast
Current therapeutic strategies for invasive and metastatic bladder cancer.
@en
prefLabel
Current therapeutic strategies for invasive and metastatic bladder cancer.
@ast
Current therapeutic strategies for invasive and metastatic bladder cancer.
@en
P2860
P356
P1476
Current therapeutic strategies for invasive and metastatic bladder cancer
@en
P2093
Jacob Mathew
Winston W Tan
P2860
P304
P356
10.2147/OTT.S22875
P407
P577
2011-07-11T00:00:00Z